Allegro Diagnostics
The profile is currenly unclaimed by the seller. All information is provided by CB Insights.
Total Raised
$9.92MInvestors Count
8Deal Terms
3Allegro Diagnostics Funding, Allegro Diagnostics Valuation & Allegro Diagnostics Revenue
5 Fundings
Allegro Diagnostics's latest funding round was a Acquired for on September 5, 2014.
Allegro Diagnostics's valuation in July 2011 was $13.3M.
Allegro Diagnostics's latest post-money valuation is from September 2014.
Sign up for a free trial to see Allegro Diagnostics's valuations in September 2014, February 2008 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
9/5/2014 | Acquired | 1 | ||||
7/7/2011 | Series A - II | $13.3M | ||||
11/25/2009 | Grant - II | |||||
10/21/2009 | Grant | |||||
2/18/2008 | Series A |
Date | 9/5/2014 | 7/7/2011 | 11/25/2009 | 10/21/2009 | 2/18/2008 |
---|---|---|---|---|---|
Round | Acquired | Series A - II | Grant - II | Grant | Series A |
Amount | |||||
Investors | |||||
Valuation | $13.3M | ||||
Revenue | |||||
Sources | 1 |
Allegro Diagnostics Deal Terms
3 Deal Terms
Allegro Diagnostics's deal structure is available for 3 funding rounds, including their Acquired from September 05, 2014.
Round | Acquired | Series A - II | Series A |
---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired | |||||||||||||||
Series A - II | |||||||||||||||
Series A |
Allegro Diagnostics Investors
8 Investors
Allegro Diagnostics has 8 investors. Veracyte invested in Allegro Diagnostics's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
9/5/2014 | 9/5/2014 | 1 Acquired | Corporation | California | ||
Venture Capital | Massachusetts | |||||
Venture Capital | Massachusetts | |||||
Government | DC | |||||
Government | DC |
First funding | 9/5/2014 | ||||
---|---|---|---|---|---|
Last Funding | 9/5/2014 | ||||
Investor | |||||
Rounds | 1 Acquired | ||||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Government | Government |
Location | California | Massachusetts | Massachusetts | DC | DC |
You May Also Like
AngioLogix is a provider of cardiovascular health diagnostics.
Dilon Technologies delivers clinically useful imaging and intra operative systems appropriate for early disease diagnosis and surgical applications. Dilon's cornerstone product, the Dilon Molecular Breast Imaging System, is a high-resolution, compact camera, and is available as a single or dual head camera. The Dilon cameras have been optimized to perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in early detection of breast cancer.
At Nanogen, Inc., the company develop diagnostic products that enable physicians to deliver improved patient care. The company's products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care. Nanogen has pioneered developments in areas involving biomarkers, molecular biology and nanotechnology. The company's business focus is to bring better results to diagnostics and healthcare.
ProteoGenix offers maternal-fetal diagnostics
Hx Diagnostics offers rapid diagnostics for seasonal and emerging infectious diseases.

Akonni Biosystems is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.